Virtus ETF Advisers’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,842
| Closed | -$71.9K | – | 508 |
|
|
2024
Q4 | $71.9K | Sell |
5,842
-1,425
| -20% | -$17.5K | 0.03% | 357 |
|
|
2024
Q3 | $88K | Buy |
7,267
+133
| +2% | +$1.61K | 0.04% | 394 |
|
|
2024
Q2 | $83.5K | Sell |
7,134
-3,367
| -32% | -$39.4K | 0.04% | 387 |
|
|
2024
Q1 | $136K | Sell |
10,501
-721
| -6% | -$9.31K | 0.07% | 339 |
|
|
2023
Q4 | $96.5K | Buy |
11,222
+5,017
| +81% | +$43.1K | 0.06% | 373 |
|
|
2023
Q3 | $59K | Sell |
6,205
-612
| -9% | -$5.82K | 0.04% | 405 |
|
|
2023
Q2 | $116K | Buy |
+6,817
| New | +$116K | 0.07% | 331 |
|